Covered recipient · General Payments record
CHRISTOPHER J GAULAND
Podiatric Medicine & Surgery Service Providers Podiatrist
General Payments · PY2018–2024
$51,973.20
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,680.00 | 1 |
| Food and Beverage | $299.36 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Austin Medical Ventures Inc | $1,680.00 | 1 |
| Abbott Laboratories | $70.16 | 3 |
| BIOCOMPOSITES INC | $46.66 | 1 |
| ABBVIE INC. | $41.79 | 3 |
| Solventum Corporation | $25.64 | 1 |
| Averitas Pharma Inc. | $25.44 | 1 |
| MIMEDX Group, Inc. | $21.48 | 1 |
| Smith & Nephew, Inc. | $20.97 | 1 |
| Nevro Corp. | $16.28 | 1 |
| Advanced Oxygen Therapy Inc. | $16.21 | 1 |
| Paratek Pharmaceuticals, Inc. | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.34 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125057649 | CMS |
| Abbott Laboratories | $21.99 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125057651 | CMS |
| Abbott Laboratories | $23.83 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125057653 | CMS |
| ABBVIE INC. | $15.02 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103781609 | CMS |
| ABBVIE INC. | $13.39 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103781611 | CMS |
| ABBVIE INC. | $13.38 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103781613 | CMS |
| Advanced Oxygen Therapy Inc. | $16.21 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111764162 | CMS |
| Austin Medical Ventures Inc | $1,680.00 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154787101 | CMS |
| Averitas Pharma Inc. | $25.44 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426873 | CMS |
| BIOCOMPOSITES INC | $46.66 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146433350 | CMS |
| MIMEDX Group, Inc. | $21.48 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140259575 | CMS |
| Nevro Corp. | $16.28 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130773586 | CMS |
| Paratek Pharmaceuticals, Inc. | $14.73 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113900745 | CMS |
| Smith+Nephew, Inc. | $20.97 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149488727 | CMS |
| Solventum Corporation | $25.64 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144096860 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.